This study is to evaluate the effect of food on pharmacokinetics of DA-5222 in healthy adult subjects
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
32
single dose administration (DA-5222 one tablet once a day)
Bumin Hospital
Seoul, South Korea, South Korea
AUCt
area under the curve
Time frame: pre-dose~72 hours post-dose
Cmax
maximum plasma concentration
Time frame: pre-dose~72 hours post-dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.